Li‐Ling Chang
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
Papers in
- Surgery 4
- Co-authors
- Chia‐Min Yang (2 shared papers)I‐Ting Teng (1 shared paper)Li-Chen Wu (1 shared paper)Lisheng Wang (1 shared paper)Ja‐an Annie Ho (1 shared paper)Jane P. F. Bai (5 shared papers)Jian‐Hwa Guo (1 shared paper)Tsong‐Min Chang (1 shared paper)
- Journals
- Journal of Pharmacy and Pharmacology (2 papers)Pharmaceutical Research (2 papers)Macromolecular Chemistry and Physics (1 paper)Biomedicines (1 paper)ACS Nano (1 paper)
- Partner nations
- United StatesTaiwanFrance
In The Last Decade
Li‐Ling Chang
15 papers receiving 373 citations
Peers
Comparison fields: 5 of 78
- Biomaterials 147
- Pharmaceutical Science 42
- Biomedical Engineering 112
- Materials Chemistry 113
- Molecular Biology 118
Countries citing papers authored by Li‐Ling Chang
This map shows the geographic impact of Li‐Ling Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Ling Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Ling Chang more than expected).
Fields of papers citing papers by Li‐Ling Chang
This network shows the impact of papers produced by Li‐Ling Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Ling Chang. The network helps show where Li‐Ling Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Li‐Ling Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 224 | |
| 2 | 2012 | 34 | |
| 3 | 1995 | 31 | |
| 4 | 1980 | 20 | |
| 5 | 2010 | 18 | |
| 6 | 1996 | 18 | |
| 7 | 2011 | 11 | |
| 8 | 1993 | 10 | |
| 9 | 2002 | 5 | |
| 10 | 1995 | 5 | |
| 11 | 2010 | 5 | |
| 12 | 1995 | 4 | |
| 13 | 2023 | 2 | |
| 14 | 2022 | 1 | |
| 15 | 2004 | 1 |
About Li‐Ling Chang
Li‐Ling Chang is a scholar working on Surgery, Molecular Biology, Cellular and Molecular Neuroscience, Oncology and Endocrinology, Diabetes and Metabolism, having authored 15 papers that have together received 389 indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (3 papers), Mesoporous Materials and Catalysis (2 papers), Phytochemicals and Antioxidant Activities (1 paper), Vitamin C and Antioxidants Research (1 paper), Porphyrin and Phthalocyanine Chemistry (1 paper), Polymer Surface Interaction Studies (1 paper), Polymer crystallization and properties (1 paper) and Adenosine and Purinergic Signaling (1 paper). The work is most often cited by research in Biomaterials (147 citations), Pharmaceutical Science (42 citations), Biomedical Engineering (112 citations), Materials Chemistry (113 citations) and Molecular Biology (118 citations). Li‐Ling Chang has collaborated with scholars based in United States, Taiwan and France. Frequent co-authors include Chia‐Min Yang, I‐Ting Teng, Li-Chen Wu, Lisheng Wang, Ja‐an Annie Ho, Jane P. F. Bai, Jian‐Hwa Guo, Tsong‐Min Chang, Huey‐Chun Huang and M. H. Aprison. Their work appears in journals such as Journal of Pharmacy and Pharmacology, Pharmaceutical Research, Macromolecular Chemistry and Physics, Biomedicines and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.